These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 25310960

  • 1. Markers of bone metabolism in children with nephrotic syndrome treated with corticosteroids.
    Pańczyk-Tomaszewska M, Adamczuk D, Kisiel A, Skrzypczyk P, Przedlacki J, Górska E, Stelmaszczyk-Emmel A, Demkow U, Roszkowska-Blaim M.
    Adv Exp Med Biol; 2015; 840():21-8. PubMed ID: 25310960
    [Abstract] [Full Text] [Related]

  • 2. Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements.
    Gulati S, Sharma RK, Gulati K, Singh U, Srivastava A.
    Nephrol Dial Transplant; 2005 Aug; 20(8):1598-603. PubMed ID: 15956073
    [Abstract] [Full Text] [Related]

  • 3. Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy.
    Fujita T, Satomura A, Hidaka M, Ohsawa I, Endo M, Ohi H.
    Calcif Tissue Int; 2000 Mar; 66(3):195-9. PubMed ID: 10666494
    [Abstract] [Full Text] [Related]

  • 4. [Dynamics of bone biochemical markers in nephrotic children treated with prednisone and metabolites of vitamin D].
    Wojnar J, Roszkowska-Blaim M, Pańczyk-Tomaszewska M.
    Przegl Lek; 2007 Mar; 64(9):552-8. PubMed ID: 18510075
    [Abstract] [Full Text] [Related]

  • 5. BONE MINERAL DENSITY IN CHILDREN WITH IDIOPATHIC HYPERCALCIURIA.
    Artemiuk I, Pańczyk-Tomaszewska M, Adamczuk D, Przedlacki J, Roszkowska-Blaim M.
    Dev Period Med; 2015 Mar; 19(3 Pt 2):356-61. PubMed ID: 26958681
    [Abstract] [Full Text] [Related]

  • 6. Bone mineral density and its influencing factors in children with idiopathic nephrotic syndrome: a prospective observational study.
    Sharawat IK, Dawman L, Kumkhaniya MV, Devpura K, Mehta A.
    Trop Doct; 2019 Oct; 49(4):292-298. PubMed ID: 31408410
    [Abstract] [Full Text] [Related]

  • 7. Effects of steroid treatment on bone mineral metabolism in children with glucocorticoid-sensitive nephrotic syndrome.
    Koşan C, Ayar G, Orbak Z.
    West Indian Med J; 2012 Sep; 61(6):627-30. PubMed ID: 23441359
    [Abstract] [Full Text] [Related]

  • 8. Bone mineral density and vitamin D status in children with remission phase of steroid-sensitive nephrotic syndrome.
    Cetin N, Gencler A, Sivrikoz IA.
    Saudi J Kidney Dis Transpl; 2019 Sep; 30(4):853-862. PubMed ID: 31464242
    [Abstract] [Full Text] [Related]

  • 9. Three-monthly bolus vitamin D supplements (1000 vs 400 IU/day) for prevention of bone loss in children with difficult-to-treat nephrotic syndrome: a randomised clinical trial.
    Singh DN, Krishnamurthy S, Kamalanathan SK, Harichandrakumar KT, Sivamurukan P.
    Paediatr Int Child Health; 2018 Nov; 38(4):251-260. PubMed ID: 30092157
    [Abstract] [Full Text] [Related]

  • 10. Effect of two prophylactic bolus vitamin D dosing regimens (1000 IU/day vs. 400 IU/day) on bone mineral content in new-onset and infrequently-relapsing nephrotic syndrome: a randomised clinical trial.
    Muske S, Krishnamurthy S, Kamalanathan SK, Rajappa M, Harichandrakumar KT, Sivamurukan P.
    Paediatr Int Child Health; 2018 Feb; 38(1):23-33. PubMed ID: 28466679
    [Abstract] [Full Text] [Related]

  • 11. Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables.
    Terzi T, Terzi M, Tander B, Cantürk F, Onar M.
    J Clin Neurosci; 2010 Oct; 17(10):1260-4. PubMed ID: 20619660
    [Abstract] [Full Text] [Related]

  • 12. Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation.
    Westeel FP, Mazouz H, Ezaitouni F, Hottelart C, Ivan C, Fardellone P, Brazier M, El Esper I, Petit J, Achard JM, Pruna A, Fournier A.
    Kidney Int; 2000 Oct; 58(4):1788-96. PubMed ID: 11012914
    [Abstract] [Full Text] [Related]

  • 13. The effect of vitamin D and calcium supplementation in pediatric steroid-sensitive nephrotic syndrome.
    Banerjee S, Basu S, Sen A, Sengupta J.
    Pediatr Nephrol; 2017 Nov; 32(11):2063-2070. PubMed ID: 28725977
    [Abstract] [Full Text] [Related]

  • 14. Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis.
    Lane NE, Sanchez S, Genant HK, Jenkins DK, Arnaud CD.
    Osteoporos Int; 2000 Nov; 11(5):434-42. PubMed ID: 10912846
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of vitamin D status bone mineral density and dental health in children with cholestasis.
    Samra NM, Emad El Abrak S, El Dash HH, El Said El Raziky M, El Sheikh MA.
    Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):368-377. PubMed ID: 29551613
    [Abstract] [Full Text] [Related]

  • 16. Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome.
    Aggarwal A, Yadav AK, Ramachandran R, Kumar V, Kumar V, Sachdeva N, Khandelwal N, Jha V.
    Nephrology (Carlton); 2016 Jun; 21(6):483-9. PubMed ID: 26428957
    [Abstract] [Full Text] [Related]

  • 17. Assessment of bone mineral density and markers of bone turnover in children under long-term oral anticoagulant therapy.
    Avgeri M, Papadopoulou A, Platokouki H, Douros K, Rammos S, Nicolaidou P, Aronis S.
    J Pediatr Hematol Oncol; 2008 Aug; 30(8):592-7. PubMed ID: 18799935
    [Abstract] [Full Text] [Related]

  • 18. Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease?
    Gulati S, Godbole M, Singh U, Gulati K, Srivastava A.
    Am J Kidney Dis; 2003 Jun; 41(6):1163-9. PubMed ID: 12776267
    [Abstract] [Full Text] [Related]

  • 19. Lumbar spine bone mineral density in diabetic children with recent onset.
    De Schepper J, Smitz J, Rosseneu S, Bollen P, Louis O.
    Horm Res; 1998 Jun; 50(4):193-6. PubMed ID: 9838239
    [Abstract] [Full Text] [Related]

  • 20. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
    Heikkinen AM, Parviainen M, Niskanen L, Komulainen M, Tuppurainen MT, Kröger H, Saarikoski S.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2476-82. PubMed ID: 9253321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.